CDC remains the dominant driver of Infratil share price and valuation, with a focus expected to shift to Asia and potential positive forward guidance from Gurin.
What is covered in the Full Insight:
Infratil FY25 Overview
One NZ Ownership and Expectations
Longroad and US Renewables Outlook
CDC's Role and Future Developments
Strategic Focus on Asia and Gurin
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.